Skip to main content
. 2021 Sep 6;137:104835. doi: 10.1016/j.compbiomed.2021.104835

Table 4.

Results of classification obtained using five-fold cross-validation for model 2.

DES Technique SE SP ACC F-1 PR
Ensemble 0.96±0.038 0.98±0.027 0.96±0.038 0.96±0.038 0.96±0.038
OLA 0.96±0.038 0.95±0.031 0.95±0.031 0.95±0.031 0.95±0.031
LCA 0.96±0.038 0.96±0.038 0.96±0.038 0.96±0.038 0.96±0.038
A-Pr 0.96±0.038 0.96±0.038 0.96±0.038 0.96±0.038 0.96±0.038
A-Po 0.96±0.038 0.96±0.038 0.96±0.038 0.96±0.038 0.96±0.038
K-E 0.96±0.038 0.96±0.038 0.96±0.038 0.96±0.038 0.96±0.038
K–U 0.97±0.020 0.96±0.038 0.96±0.038 0.96±0.038 0.96±0.038